N4 Pharma Plc 0GO.F Stock
N4 Pharma Plc Price Chart
N4 Pharma Plc 0GO.F Financial and Trading Overview
N4 Pharma Plc stock price | 0.0010 EUR |
Previous Close | 0.01 EUR |
Open | 0.01 EUR |
Bid | 0.0095 EUR x N/A |
Ask | 0.04 EUR x N/A |
Day's Range | 0.01 - 0.01 EUR |
52 Week Range | 0.008 - 0.06 EUR |
Volume | 600 EUR |
Avg. Volume | 0 EUR |
Market Cap | 4.98M EUR |
Beta (5Y Monthly) | -0.108812 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.01 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
0GO.F Valuation Measures
Enterprise Value | 652.05K EUR |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 1.1111112 |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | N/A |
Trading Information
N4 Pharma Plc Stock Price History
Beta (5Y Monthly) | -0.108812 |
52-Week Change | -55.0000000000000071% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.06 EUR |
52 Week Low | 0.008 EUR |
50-Day Moving Average | 0.01 EUR |
200-Day Moving Average | 0.01 EUR |
0GO.F Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 233.78M |
Float | 202.46M |
Short Ratio | N/A |
% Held by Insiders | 13.28% |
% Held by Institutions | 0% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -33.084% |
Return on Equity (ttm) | -48.80% |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | N/A |
Net Income Avi to Common (ttm) | -1029261 EUR |
Diluted EPS (ttm) | -0.01 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 1.92M EUR |
Total Cash Per Share (mrq) | 0.008 EUR |
Total Debt (mrq) | 0 EUR |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 27.809 |
Book Value Per Share (mrq) | 0.009 |
Cash Flow Statement
Operating Cash Flow (ttm) | -828263 EUR |
Levered Free Cash Flow (ttm) | -544789 EUR |
Profile of N4 Pharma Plc
Country | Germany |
State | N/A |
City | London |
Address | 60 Gracechurch Street |
ZIP | EC3V 0HR |
Phone | 44 1332 690061 |
Website | https://www.n4pharma.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 5 |
N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
Q&A For N4 Pharma Plc Stock
What is a current 0GO.F stock price?
N4 Pharma Plc 0GO.F stock price today per share is 0.0010 EUR.
How to purchase N4 Pharma Plc stock?
You can buy 0GO.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for N4 Pharma Plc?
The stock symbol or ticker of N4 Pharma Plc is 0GO.F.
Which industry does the N4 Pharma Plc company belong to?
The N4 Pharma Plc industry is Drug Manufacturers-Specialty & Generic.
How many shares does N4 Pharma Plc have in circulation?
The max supply of N4 Pharma Plc shares is 2.36B.
What is N4 Pharma Plc Price to Earnings Ratio (PE Ratio)?
N4 Pharma Plc PE Ratio is now.
What was N4 Pharma Plc earnings per share over the trailing 12 months (TTM)?
N4 Pharma Plc EPS is -0.01 EUR over the trailing 12 months.
Which sector does the N4 Pharma Plc company belong to?
The N4 Pharma Plc sector is Healthcare.